Event Content

For decades, GELITA has been providing specialized collagen for vaccine stabilization and applications in bioscience. This presentation delves into the production and use of recombinant collagen proteins and peptides, focusing on their role in vaccine stabilization and various biomedical applications. As w...

The CDMO industry is at an inflection point. The explosive demand for GLP-1 therapies is straining manufacturing capacity, forcing rapid investment in specialized capabilities. Geopolitical tensions are disrupting supply chains, making regional diversification and de-risking strategies more critical than e...

Continuous manufacturing: A view into the Future of Pharmaceuticals Production Pharmaceutical manufacturing is evolving. As the industry looks for ways to enhance efficiency, improve quality, and strengthen supply chains, continuous manufacturing is emerging as a powerful alternative to traditional batch p...

Navigating the evolving terrain of biologics from development through commercialization requires a resilient and dependable supply chain. Dual sourcing, which involves procuring essential materials from two distinct suppliers, has emerged as a pivotal strategy to help mitigate risks and enhance supply chai...

Amid growing global demands and complexities, resilience and agility have become essential for success in today’s pharmaceutical supply chains. The COVID-19 pandemic, geopolitical tensions, and reliance on foreign manufacturing have underscored vulnerabilities in the supply of APIs—the building blocks of m...

• Alternative Approaches to Boost Patient Enrolment Amid Recruitment Challenges • How the Rising Pressures of Patient Recruitment Are Challenging Traditional Enrolment Methods

A review of various methods and instrumentation, including the benefits and limitations for each in biomanufacturing. Regulatory views, including description of use/acceptance at each phase of drug discovery from pre-clinical through BLA. Case Study.

This panel brings together experts to discuss the latest technological breakthroughs revolutionizing advanced bio-manufacturing. From AI-driven automation to cutting-edge bioprocessing tools, we’ll examine how these innovations are enhancing scalability, precision, and efficiency in biologics production. ...

Aptar Pharma's presentation entitled " A broad range of advanced delivery platforms " explores the current extensive portfolio of high-quality OIDP (Orally Inhaled Drug Products) delivery devices. The presentation also highlights Aptar Pharma's comprehensive services which support respiratory drug developm...

This presentation will cover the critical steps to follow when qualifying a product for the irradiation sterilization process: • Qualification of the sterilization dose • Qualification of the maximal acceptable dose • The presentation will: • -Explain the current process mainly used in the med...

The presentation will delve into how the LOG Pharma Primary Packaging team have addressed the challenge of designing eco-friendly oxygen and moisture barrier bottles. It will highlight the complexities of developing sustainable primary packaging for pharmaceuticals that comply with environmental standard...

Global markets are increasingly penalizing linear business models that harm the environment and society, making a strong case for sustainable practices. In pharmaceutical packaging, this shift demands rethinking strategies to maximize resource efficiency while protecting human and planetary health. As pack...

The global gummy vitamin market is expected to reach 10.6 billion by 2025 and gummies are gaining traction as a drug delivery system -- especially for children and seniors who resist taking pills, capsules and liquids. Mitchell Slade, who brings more than 20 years of gummy manufacturing experience at Natur...

Big Pharma reports that up to over 90% of their CO2 emissions are scope 3. This is not only a huge burden but also the most difficult part to influence for pharmaceutical industry. However, there are ways to manage and collaborate in the industry. Christophe Marie from Aptar Group will highlight how Aptar ...

Discover highly bioavailable liposomal iron, Liposovit®-Fe • Join us to: • • Understand Iron Deficiency: • o Learn about the global impact and at-risk groups for iron deficiency and anemia. • • Explore Liposovit®-Fe: • o Discover the benefits of Liposovit®-Fe’s advanced liposomal technology....

Africa stands at the cusp of unprecedented growth, offering a wealth of opportunities for strategic partnerships and investment.  Unprecedented momentum in catalytic initiatives for ecosystem development offer potential for unlocking aggregate commercial opportunity greater than $20Bn.  By fostering collab...

Discover the compelling link between employee wellness, engagement, and company success. Learn practical strategies to enhance employee well-being, boost recruitment efforts, and cultivate a positive corporate culture. Explore how wellness initiatives drive sales performance and leadership effectiveness. G...

Difficulties Meeting US FDA Regulatory Requirements

The presentation will highlight how we can use bio attributed polymers to reduce the carbon footprint without compromising product safety. With certified bio circular raw materials polymers can be produced to enable our customers to reduce their carbon footprint.

As the landscape, development, and introduction of large-volume delivery systems continue to grow, the implementation of these devices in the Pharma ecosystem creates unique challenges for pharmaceutical companies. From the selection of drug containment materials and enclosures, to device assembly needs to...

Meet industry sustainability experts in an informal setup for an open discussion on what matters the most for you as part of the Pharma industry. What are your current sustainability planning issues and how could you solve them? What could be your next steps and with whom do you need to collaborate to reac...

OXYCAPT
• OXYCAPT Multilayer Plastic Vial for Biologics and Gene/Cell Therapy • High Oxygen, CO2 and UV Barrier suitable for Biologics and Gene/Cell Therapy • Extremely Low Inorganic Extractables Suitable for Biologics and Gene/Cell Therapy • New Container Closure Integrity (CCI) Data ...

BSI – set the scene of the challenge of manufacturing antibiotics and the environment - 3 mins
Centrient – what we have done so far to invest in mitigating environmental threat?– 5 mins BSI – One Health approach towards setting industry standard and certification for combatting antibiotics dischar...

• Ensuring quality and compliance in bio-manufacturing • Closing gaps in development data prior to the first GMP production • Adjusting manufacturing processes throughout the course of a site-to-site transfer • Fulfilling special requirements on container closure systems for biologics • ...

We finished off the day by learning to understand the latest trends and developments in the CDMO space, and strategies for developing successful partnerships. • Market trends and developments in the CDMO space • Reviewing your in-house capabilities to determine what services you need • Best pract...

The European ban on the use of titanium dioxide for food use has called into question its use in pharmaceutical products because its pharmaceutical use was predicated on its approval for food use. The European ban is not based on hard science or a real safety issue, but on the precautionary principle. This...

Get the inside focus on the latest drug pricing developments in the US market. Listen to the current legislator updates and how it will affect patient costs while reviewing the rising manufacturing costs from inflation and supply constraints and the market’s reaction: • Examining current manufacture ...

Pharmaceutical and other healthcare innovations have extended and improved countless lives in recent decades. Today, advanced manufacturing technologies such as pharmaceutical continuous manufacturing are gaining increasing interest for their potential to serve as one more way to improve global health by b...

With US Pharma pledging to become net-zero by 2050, you must have the right processes. Join our focused panel where our experts will discuss the best ways to implement ESG in your organization: • Defining ESG in Pharma to understand what makes it different from other industries • Establishing what i...

This session will give insights on the trends our sector is facing: decarbonization and circular economy. It will also provide an overview on the work done at industry level. And finally, you will be able to learn more on what Saint-Gobain Life Sciences is willing to offer to supply single-use technologies...

Sub-optimal adherence and persistence to treatment continue to be significant challenges for both on-market drugs and investigational products in clinical development. This is especially true for self-administered medications for chronic disease patients, hence driving the need for improved treatment intak...

Lyophilization (freeze drying) is a proven process for increasing the shelf life of vaccines, biologics and other injectables. But delivering these products requires several use steps that make them challenging to administer, particularly by patients and caregivers in non-clinical settings. To address thes...

This session will help you understand real-world life as a student entering the Pharma industry post-pandemic. We will learn more about the role a CDMO plays in the pharmaceutical industry and the importance of hiring university and school early careers from the lens of a business leader. Finally, we will ...

Have you wondered what value digital health brings to health systems?

This session will cover the ~25 main digital health value pools on health system level and show what value digital health solutions provide. In addition, digital health reimbursement is addressed, with a particular focus on t...

OXYCAPT is a multilayer plastic vial that consists of three layers, COP/New Polyester/COP. The product has achieved excellent oxygen & ultraviolet (UV) light barrier, very low extractables, high pH stability, low protein adsorption, high transparency, high break resistance, lightweight, etc. For example, t...

This short session answers the most pressuring strategic questions with regards to sustainability: Why does it matter? Where to focus? How is it measured? What is the current industry status? How to improve?

Did you enjoy this session? If so, you might like to visit our Connect to Frankfurt plat...

In this webinar, originally broadcast as part of the Pharmapack Europe show, Corinne Ondo, Head of Sourcing Production Materials Biotech & Healthcare Innovation, Merck discusses how Healthcare is currently improving packaging reuse in its supply chain by working in close partnership with its suppliers. By...

In this webinar, originally part of Pharmapack Europe 2022, Bernd Garska, Technical Marketing Manager Healthcare EMEA, Covestro AG discusses how until now, drug delivery devices would require tedious sorting with a variety of materials used in various components. Now, with an all-polycarbonate device, mini...

In this webinar, originally broadcast as a part of Pharmapack Europe, Eve-Marie Vaccaro, Global Sales & Operation Planner, and Edgar Bauer, Global Key Account Manager Bausch+Ströbel from BD Medical - Pharmaceutical Systems discuss how VHP sterilization is a viable alternative for ensuring improved patient ...

In this webinar, originally part of Pharmapack Europe 2022, Thomas Watts, Engineering Consultant, Team Consulting discusses tackling the challenges of cloud connectivity. The electronic Product Information initiative for Medicines (ePI) aim to ease the accessibility on product information to everyone with...

Recent Congressional proposals have been targeted at drug pricing reform, including opportunities to allow Medicare to negotiate prices for certain drug products, penalizing prices that rise faster than the rate of inflation, and capping out-of-pocket costs for beneficiaries in the Medicare Part D program....

Talk of bringing back domestic manufacturing to North America has dominated conversations around pharma manufacturing for years, and have been a key talking point in government post-pandemic recovery plans, but how far have we come and who is this really working for? Asian CDMO’s recognizing the trend f...

This presentation will provide an overview of the differences and similarities of E&L requirements between pharmaceutical products and medical devices. The key elements regarding E&L testing design of combination products will be discussed. Several case studies on the extractables and leachables testing of...

Q&A featuring Raman Sehgal, host of Molecule to Market and Stephanie Watson, Global Strategy and Commercial Planning Lead at Pfizer CentreOne Diving into the biggest challenges the supply chain are currently facing, as well as potential solutions Dissect successful responses and shed light on the future tr...